Get our lovely INSIGHT 2019 conference news

Email address
First Name
Last Name
Interested in InSight 2019

What are you looking for?

<Good_things_happen/> Welcome to Conference

Pharmacological and psychological predictors of the MDMA response in placebo-controlled studies in healthy subjects

Oral Presentation

3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) is used both recreationally and therapeutically. The pharmacodynamic effects of MDMA are diverse. Little is known about individual differences in the acute response to MDMA. Previous studies suggest that differences in the response to MDMA are in part due to genetic variations in the metabolism of MDMA. Additionally, effects of other psychoactive substances have been shown to be critically influenced by personality traits and mood states before drug intake.
Methods: The present analysis was based on 10 randomized, double-blind, placebo-controlled, cross-over studies with a total of 194 healthy subjects receiving either 75 or 125 mg of MDMA. The present study investigated the influence of 18 variables (sex, age, drug exposure, body weight, genetically determined enzyme activity, previous drug experience, personality [NEO-FFI, and trait anxiety in the State-Trait Anxiety Inventory, STAI-T], and mood before drug intake [Adjective Mood Rating Scale, AMRS]) on the peak autonomic and total subjective responses to MDMA (measured with visual analog scales [VAS], and the five Dimensions of Altered States of Consciousness scale [5D-ASC]). Multiple linear mixed effects models were fitted for each of the response variables. Results were adjusted for MDMA dose per bodyweight and corrected using the Benjamini-Hochberg procedure.
The variable which best predicted the responses to MDMA was the MDMA plasma concentration. It correlated with the mean arterial pressure as well as with ratings of “any drug” effects (p<0.05 and p<0.01, respectively). Subject’s openness to experiences as a trait measure was positively correlated with VAS ratings of “closeness”, and 5D-ASC ratings of “oceanic boundlessness” and visionary restructuralization” after MDMA (p<0.05, p<0.05, and p<0.01). NEO-FFI “neuroticism” and STAI “trait anxiety” positively correlated with 5D-ASC “dread of ego dissolution” (p<0.001 and p<0.01, respectively). Additionally, the acute response on the 5D-ASC subscale “anxiety” positively correlated with AMRS “anxiety-depressiveness” and “introversion” before drug intake (both p<0.05).
Although drug plasma concentration was the most important predictor of the acute response to MDMA, psychological factors such as trait openness to new experiences and state mood before drug intake also significantly predicted the subjective drug effects of MDMA. The results confirm that both pharmacological and non-pharmacological psychological factors play an important role in the anticipated subjective effects of MDMA, and could potentially be considered when using MDMA in psychiatric settings.



September 7th 2019




Room: Bernahrd von Langenbeck
Patrick Vizeli

Patrick Vizeli

University of Basel more about the speaker

Conference tickets

With your ticket you will have access to the whole conference - with keynotes, panels, round tables, posters and daylight social events. We will ask for a small extra fee for the Friday evening social program. The pre-conference workshops have to be booked separately and each workshop needs an individual ticket. By clicking on "Book now" below you also have the option to buy your workshop tickets.

*Reduced fees apply to students, cooperation partners as well as unemployed and retired individuals who have a monthly net income below 840,- €. Proof of status will be required.

THE CONFERENCE IS SOLD OUT! Subscribe to our newsletter to become an early bird for 2021!

Get our lovely INSIGHT 2019 conference news

Email address
First Name
Last Name